» Articles » PMID: 37371552

Cellular and Molecular Activities of IP6 in Disease Prevention and Therapy

Overview
Journal Biomolecules
Publisher MDPI
Date 2023 Jun 28
PMID 37371552
Authors
Affiliations
Soon will be listed here.
Abstract

IP6 (phytic acid) is a naturally occurring compound in plant seeds and grains. It is a poly-phosphorylated inositol derivative that has been shown to exhibit many biological activities that accrue benefits in health and diseases (cancer, diabetes, renal lithiasis, cardiovascular diseases, etc.). IP6 has been shown to have several cellular and molecular activities associated with its potential role in disease prevention. These activities include anti-oxidant properties, chelation of metal ions, inhibition of inflammation, modulation of cell signaling pathways, and modulation of the activities of enzymes and hormones that are involved in carbohydrate and lipid metabolism. Studies have shown that IP6 has anti-oxidant properties and can scavenge free radicals known to cause cellular damage and contribute to the development of chronic diseases such as cancers and cardiovascular diseases, as well as diabetes mellitus. It has also been shown to possess anti-inflammatory properties that may modulate immune responses geared towards the prevention of inflammatory conditions. Moreover, IP6 exhibits anti-cancer properties through the induction of cell cycle arrest, promoting apoptosis and inhibiting cancer cell growth. Additionally, it has been shown to have anti-mutagenic properties, which reduce the risk of malignancies by preventing DNA damage and mutations. IP6 has also been reported to have a potential role in bone health. It inhibits bone resorption and promotes bone formation, which may help in the prevention of bone diseases such as osteoporosis. Overall, IP6's cellular and molecular activities make it a promising candidate for disease prevention. As reported in many studies, its anti-inflammatory, anti-oxidant, and anti-cancer properties support its inclusion as a dietary supplement that may protect against the development of chronic diseases. However, further studies are needed to understand the mechanisms of action of this dynamic molecule and its derivatives and determine the optimal doses and appropriate delivery methods for effective therapeutic use.

Citing Articles

Inositol Phosphates and Synthesizing Enzymes: Implications in Neurodegenerative Disorders.

Onu C, Adu M, Chakkour M, Kumar V, Greenberg M Biomolecules. 2025; 15(2).

PMID: 40001529 PMC: 11853280. DOI: 10.3390/biom15020225.


Multi-omics approach to reveal follicular metabolic changes and their effects on oocyte competence in PCOS patients.

Chen Y, Xie M, Wu S, Deng Z, Tang Y, Guan Y Front Endocrinol (Lausanne). 2024; 15:1426517.

PMID: 39464191 PMC: 11502346. DOI: 10.3389/fendo.2024.1426517.


Inositol Hexaphosphate in Bone Health and Disease.

Yoshiko Y, Vucenik I Biomolecules. 2024; 14(9).

PMID: 39334839 PMC: 11430719. DOI: 10.3390/biom14091072.


Grains in a Modern Time: A Comprehensive Review of Compositions and Understanding Their Role in Type 2 Diabetes and Cancer.

Khan J, Gul P, Liu K Foods. 2024; 13(13).

PMID: 38998619 PMC: 11241577. DOI: 10.3390/foods13132112.


Depleting inositol pyrophosphate 5-InsP7 protected the heart against ischaemia-reperfusion injury by elevating plasma adiponectin.

Fu L, Du J, Furkert D, Shipton M, Liu X, Aguirre T Cardiovasc Res. 2024; 120(8):954-970.

PMID: 38252884 PMC: 11218692. DOI: 10.1093/cvr/cvae017.

References
1.
Song H, Deng X, Yuan G, Hou X, Zhu Z, Zhou L . Expression of bcl-2 and p53 in induction of esophageal cancer cell apoptosis by ECRG2 in combination with cisplatin. Asian Pac J Cancer Prev. 2014; 15(3):1397-401. DOI: 10.7314/apjcp.2014.15.3.1397. View

2.
Moon H, Matarese G, Brennan A, Chamberland J, Liu X, Fiorenza C . Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance. Diabetes. 2011; 60(6):1647-56. PMC: 3114380. DOI: 10.2337/db10-1791. View

3.
Shao Y, Cheng Z, Li X, Chernaya V, Wang H, Yang X . Immunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction--a novel mechanism for maintaining vascular function. J Hematol Oncol. 2014; 7:80. PMC: 4236671. DOI: 10.1186/s13045-014-0080-6. View

4.
Toyoshima Y, Gavrilova O, Yakar S, Jou W, Pack S, Asghar Z . Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes. Endocrinology. 2005; 146(9):4024-35. DOI: 10.1210/en.2005-0087. View

5.
Brehm M, Klemm U, Rehbach C, Erdmann N, Kolsek K, Lin H . Inositol hexakisphosphate increases the size of platelet aggregates. Biochem Pharmacol. 2018; 161:14-25. PMC: 6372069. DOI: 10.1016/j.bcp.2018.12.011. View